There are 1,270 Biopharma investors in the AngelBacked database, ranked below by portfolio size. The most active include David Tisch, Esther Dyson and Peter Erin, CFA. Each profile lists portfolio companies, sector focus, check size, and contact details.
Venture Capital Investment and Investor Relations
Sign up to view contact details, LinkedIn profiles, and export investor data.
AngelBacked lists 1,270 angel investors and VCs who invest in Biopharma startups. The most active by portfolio size include David Tisch, Esther Dyson, Peter Erin, CFA.
Ranked by number of portfolio companies, the most active Biopharma investors in the AngelBacked database are David Tisch, Esther Dyson, Peter Erin, CFA. Each profile lists their portfolio, sector focus, and contact details.
Every Biopharma investor profile on AngelBacked includes a verified email address alongside their portfolio companies, sector focus, and firm. Paid plans unlock the contact details and CSV export.
Check sizes vary by stage: angel investors backing Biopharma startups typically write $25K–$100K, while Biopharma-focused VCs range from $500K to $5M+ for early-stage rounds. Filter the database by check size to match your raise.